Effect of Fixed vs. Tailored Intensity tDCS for Attention Deficit After TBI
Traumatic Brain Injury, Attention Deficit, Cognitive Impairment
About this trial
This is an interventional treatment trial for Traumatic Brain Injury focused on measuring traumatic brain injury, attention deficit, transcranial direct current stimulation
Eligibility Criteria
Inclusion Criteria:
- 19 years or older
- At least 6 months since traumatic brain injury
- Cognitive disability measured by:
A) K-MoCA score 25 or below, or B) Trail making test A > 50.25s or B > 142.53s
Exclusion Criteria:
- Infection, open wound, bleeding, skull defect, or metal plates at or near tDCS site
- history of seizure
- Language disorder
- Serious cognitive deficit with K-MoCA score below 10
- Pregnancy or possibility of pregnancy
- MRI contraindications
- Previous medical history that may affect the patient's cognitive abilities (i.e. previous stroke, hypoxic ischemic encephalopathy, schizophrenia)
- Change in dosage of the following medications within the previous 2 weeks
- rivastigmine
- donepezil
- memantine
- antiepiletic medications
Sites / Locations
- Seoul National University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Sham Comparator
Active Comparator
Experimental
Sham tDCS Group
Conventional tDCS Group
Tailored tDCS Group
Sham transcranial direct current stimulation using YMS-201B(YBrain, Daejeon, Korea); ramp-up 30sec to 1.5mA, 0mA stimulation for 19 min 30 sec.
Transcranial direct current stimulation using YMS-201B(YBrain, Daejeon, Korea); ramp-up 30sec to 1.5mA, continuous 1.5mA stimulation for 19 minutes, ramp-down 30sec to 0mA.
Transcranial direct current stimulation using YMS-201B(YBrain, Daejeon, Korea); ramp-up 30sec to 2.0mA, continuous 2.0mA stimulation for 19 minutes, ramp-down 30sec to 0mA.